Skip to main content
Premium Trial:

Request an Annual Quote

Roche Set to Become Majority Shareholder of Foundation Medicine

NEW YORK (GenomeWeb) – Roche today announced it is set to become the majority shareholder of Foundation Medicine following the preliminary results of the closing of its tender offer at the end of the day on Monday.

Under the tender offer, announced in January, Roche proposed to purchase approximately 15.6 million shares of common stock of Foundation Medicine for $50 per share, for an aggregate value of around $780 million. The offer expired at midnight EDT Monday.

Roche said that based on preliminary results by Citibank, the depositary for the tender offer, Foundation Medicine shareholders tendered a total of 17.5 million shares, not including 1.9 million shares that were tendered by notice of guaranteed delivery. Together with shares already owned by Roche and 5 million newly issued shares Roche will acquire directly from the company at $50 per share, Roche will own approximately 62.8 percent of Foundation Medicine's outstanding shares of common stock on a fully diluted basis.

Since the offer was oversubscribed, Roche will prorate the percentage of shares it will purchase from each tendering stockholder to about 80 percent in order to limit its total purchase to the 15.6 million shares agreed upon by the two firms in January.

Roche said it will announce the final results for the offer after the expiration of the guaranteed delivery period and completion of the confirmation process.

Foundation Medicine stockholders had approved Roche's tender offer in a special meeting last week.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.